index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

88

 

NOTICES

152

 

 

MOTS CLES

Cardio-oncology Antibiotics Prostate cancer Azathioprine Anti-Bacterial Agents Immunotherapy Glucocorticoids Alitretinoin Epidemiology Aging Meta-Analysis Addiction Abus d'antibiotiques Angiotensin-converting enzyme inhibitors Adolescent Ustekinumab Angiotensin receptor blockers Ankylosing Cardiotoxicity Antibiotic misuse BTK protein Autoimmune diseases Dermatology CTLA-4 Access to care Auto-Diagnostic Drug survival Burden Sipuleucel-T ASDAS Accelerometer ArtThese Pregnancy Biological therapy Etanercept Placebo Antimicrobials Antimicrobiens Biologic drug Drug reaction Arthritis Immune checkpoint inhibitors COVID-19 Beta-lactam antibiotics Spondylitis Biosimilar Pharmaceuticals Spondyloarthritis Endocrine toxicity Cardiomyopathy Psoriatic arthritis Antibiotic resistance Biomarkers Antimicrobial Stewardship Albinism Vigibase® Apre-milast Graft-versus-host disease Ankylosing spondylitis Atrial fibrillation Primary adrenal insufficiency Pharmaco-Épidémiologie Apremilast Auto-immune hepatitis Immune-related adverse events Quality of life Atopic dermatitis Intensive care Acute Myeloid Leukaemia AML Autoimmunity Psoriasis Amyloidosis Ethics Cancer Infliximab Adverse side effects Biologic Bacterial rhinosinusitis Biologics Management Biomédicaments Alcohol Anti-HCV Direct Acting Antivirals DAA Anticancer drugs Pharmacovigilance Pharmacoepidemiology Anti-TNF Anxiety Antimicrobial resistance Adalimumab Sacroiliitis Axial spondyloarthritis CSK tyrosine-protein kinase Bacterial Anxiété Treatment Stability Biological Therapy Méta-Analyse Biologic therapy Arrhythmia

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS